Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.26
-0.02 (-0.27%)
At close: Apr 16, 2026
Market Cap4.52B -7.3%
Revenue (ttm)873.36M +8.1%
Net Income7.95M -90.2%
EPS0.01 -90.9%
Shares Out622.33M
PE Ratio568.33
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,040,000
Average Volume6,784,840
Open7.30
Previous Close7.28
Day's Range7.00 - 7.30
52-Week Range6.12 - 25.00
Beta-0.06
RSI53.19
Earnings DateMar 30, 2026

About HKG:6955

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 714
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2025, HKG:6955's revenue was 784.82 million, an increase of 8.06% compared to the previous year's 726.32 million. Earnings were 7.14 million, a decrease of -90.24%.

Financial numbers in CNY Financial Statements